DOSSIERS / HRA PHARMA DEVELOPMENT
← SearchExport PDF
Company dossier

HRA PHARMA DEVELOPMENT

FRANCE · COMPANY · INCORPORATED 2000-10-30
KYBE ID: FR-433432176 · 433432176 · 2 sources
RISK SCORE7LOW RISK

Key facts

dissolved
HRA PHARMA DEVELOPMENT
fr_insee
433432176
fr_insee
dissolved
fr_insee
Limited liability company (SARL)
fr_insee
2000-10-30
fr_insee
2021-12-31
fr_insee
200 AV DE PARIS, 92320 CHATILLON
fr_insee
46.46Z
fr_insee
€8,000
fr_insee

Ownership structure

1 entities

No ownership links on record for this entity.

People with significant control

1 people
NameRoleFromSource
DAVID WRIGHTPrésidentFrance registry

Risk signals

3 matched
medium

Shared-director cluster

A director is shared across 8 companies

medium

Politically exposed person (PEP)

DAVID WRIGHT (officer) matches PEP David Wright — member of the 54th Parliament of the United Kingdom, United Kingdom. Apply enhanced due diligence.

medium

Politically exposed person (PEP)

DAVID WRIGHT (officer) matches PEP David Wright — member of the 55th Parliament of the United Kingdom, United Kingdom. Apply enhanced due diligence.

Risk journey — why 7?

3 signals
+7
Shared-director cluster
+0
Politically exposed person (PEP)
+0
Politically exposed person (PEP)
Composite risk score7/100

Insolvency timeline

1 events
Dissolved / struck off